Daxor Corporation

NasdaqCM:DXR Stock Report

Market Cap: US$58.9m

Daxor Management

Management criteria checks 4/4

Daxor's CEO is Michael Feldschuh, appointed in Sep 2016, has a tenure of 9.75 years. total yearly compensation is $100.93K, comprised of 99.1% salary and 0.9% bonuses, including company stock and options. directly owns 3.67% of the company’s shares, worth $2.16M. The average tenure of the management team and the board of directors is 7.9 years and 7.9 years respectively.

Key information

Michael Feldschuh

Chief executive officer

US$100.9k

Total compensation

CEO salary percentage99.08%
CEO tenure9.8yrs
CEO ownership3.7%
Management average tenure7.9yrs
Board average tenure7.9yrs

Recent management updates

Recent updates

Seeking Alpha • Aug 25

Daxor reports Q2 results

Daxor press release (NASDAQ:DXR): Q2 The increase in revenue of 92.6 percent in the Company’s operating division represents strong strides in the commercialization of its BVA-100. As of June 30, 2022 the company held net assets of $19,615,712 or $4.85 per share, a 35.3 percent increase versus the same period in the prior year.
Seeking Alpha • Jul 21

Daxor partners with Medaxiom to advance awareness of blood volume diagnostic

Daxor (NASDAQ:DXR) said it had partnered with Medaxiom to advance awareness and adoption of Daxor’s blood volume diagnostic. "With heart failure diagnosis continuing to increase, access to accurate blood volume testing will transform the way care decisions are made,” said Joe Sasson, MedAxiom’s EVP of Ventures.
Analysis Article • Mar 08

Daxor's (NASDAQ:DXR) Earnings Aren't As Good As They Appear

We didn't see Daxor Corporation's ( NASDAQ:DXR ) stock surge when it reported robust earnings recently. We decided to...
Analysis Article • Feb 27

A Look At The Fair Value Of Daxor Corporation (NYSEMKT:DXR)

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Daxor Corporation...

CEO Compensation Analysis

How has Michael Feldschuh's remuneration changed compared to Daxor's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025US$101kUS$100k

US$9m

Sep 30 2025n/an/a

US$5m

Jun 30 2025n/an/a

US$2m

Mar 31 2025n/an/a

US$1m

Dec 31 2024US$101kUS$100k

US$536k

Sep 30 2024n/an/a

US$1m

Jun 30 2024n/an/a

US$2m

Mar 31 2024n/an/a

US$984k

Dec 31 2023n/an/a

US$281k

Sep 30 2023n/an/a

US$2m

Jun 30 2023n/an/a

US$4m

Mar 31 2023n/an/a

US$5m

Dec 31 2022US$100kUS$100k

US$5m

Sep 30 2022n/an/a

US$5m

Jun 30 2022n/an/a

US$4m

Mar 31 2022n/an/a

US$5m

Dec 31 2021US$100kUS$100k

US$5m

Sep 30 2021n/an/a

US$3m

Jun 30 2021n/an/a

US$294k

Mar 31 2021n/an/a

-US$706k

Dec 31 2020US$100kUS$100k

-US$2m

Sep 30 2020n/an/a

-US$3m

Jun 30 2020n/an/a

-US$4m

Mar 31 2020n/an/a

-US$2m

Dec 31 2019US$100kUS$100k

-US$496k

Compensation vs Market: Michael's total compensation ($USD100.93K) is below average for companies of similar size in the US market ($USD642.98K).

Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.

CEO

Michael Feldschuh (57 yo)

9.8yrs
Tenure
US$100,925
Compensation

Mr. Michael Richard Feldschuh has been the Chief Executive Officer and President of Daxor Corporation since September 21, 2016 and since 2017 respectively. Mr. Feldschuh served as Acting Chief Executive Of...

Leadership Team

NamePositionTenureCompensationOwnership
Michael Feldschuh
Chairman9.8yrsUS$100.93k3.67%
$ 2.2m
Robert Michel
CFO, Chief Compliance Officer & Corporate Secretary7.8yrsUS$151.39k0.36%
$ 212.6k
Jonathan Feldschuh
Chief Scientific Officer & Director9.4yrsUS$151.39k0.93%
$ 544.5k
John Jefferies
Chief Medical Officer2.1yrsUS$299.48k0.40%
$ 237.9k
Linda Cooper
Vice President of Development & Operations3.4yrsno datano data
Kathryn Kornafel
Senior VP of Marketing & Commercial Development8yrsno datano data
7.9yrs
Average Tenure
59yo
Average Age

Experienced Management: DXR's management team is seasoned and experienced (7.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Michael Feldschuh
Chairman13.4yrsUS$100.93k3.67%
$ 2.2m
Jonathan Feldschuh
Chief Scientific Officer & Director9.3yrsUS$151.39k0.93%
$ 544.5k
Phillip Frost
Chairman of Medical Advisory Boardno datano datano data
Caleb DesRosiers
Independent Director6.4yrsUS$2.50k0.054%
$ 31.9k
Fred Gilbert
Member of Medical Advisory Boardno datano datano data
James Brassel
Member of Medical Advisory Boardno datano datano data
Edward Feuer
Independent Director10.4yrsUS$2.50k0.017%
$ 10.1k
Henry Cremisi
Independent Director6yrsUS$1.50kno data
Joy Goudie
Independent Director6yrsUS$2.50k0.0052%
$ 3.0k
7.9yrs
Average Tenure
68yo
Average Age

Experienced Board: DXR's board of directors are considered experienced (7.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/09 08:52
End of Day Share Price 2026/06/09 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Daxor Corporation is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Frank TakkinenLake Street Capital Markets, LLC
Scott HenryRoth Capital Partners